All News & Stories

March 28, 2019

Geneva Supports Ebola Research Advancement

The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), in collaboration with Geneva and Gilead Sciences, Inc., has announced that the U.S. Food and Drug Administration (FDA) has provided formal regulatory agreement for use of an animal model to support development of a drug candidate, remdesivir, for treating deadly Ebola virus (EBOV) infections. USAMRIID

Read more
March 13, 2019

Geneva’s Small Grant Competition @JBLM

Thanks to a generous contribution from the LT Murray Family Foundation, Geneva is pleased to announce the first small grant competition for researchers at Joint Base Lewis-McChord! Geneva’s Scientific Advisory Board will be evaluating project proposals that are related to military medical research and are either pilot projects that enable the researcher to collect preliminary

Read more
March 11, 2019

Geneva Announces New Chair of Board of Directors

Geneva’s Board of Directors recently elected Major General (Ret.) Frank Scoggins as its new Chair. Having served on Geneva’s Board since 2011, Major General Scoggins has demonstrated an active engagement in the success and growth of the organization’s mission, programmatic growth, and long-term financial sustainability. Major General Scoggins retired from the U.S. Air Force (USAF)

Read more
March 6, 2019

Dr. Kenneth Bertram Joins Geneva’s Board of Directors

Geneva is pleased to announce the addition of Dr. Kenneth Bertram to the Board of Directors. Dr. Kenneth A. Bertram is the Clinical Product Development Officer for the Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC. In this position, he leads a team conducting early clinical trials using human stem cells to regulate the body’s

Read more
February 8, 2019

Geneva Launches CMIRR

The Uniformed Services University (USU) recently issued a Cooperative agreement to Geneva to facilitate the execution of the Collaboratory for Musculoskeletal Injury Rehabilitation Research (CMIRR). CMIRR is a four-year, $15M program funded by the Defense Health Agency (DHA), with the purpose of improving a rehabilitative approach to caring for military service members with musculoskeletal injury

Read more
February 6, 2019

Join the Conversation Recap

Geneva’s first 2019 Join the Conversation event on 5 February featuring Geneva researcher and employee Dr. Brad Isaacson was a resounding success. After a welcoming address and the honoring of outgoing Board Chair Michael Hansch from Founder & Chief Strategy Officer Jane Taylor, Board of Directors Chair Major General (Ret.) Frank Scoggins and President &

Read more
January 25, 2019

Q4 Wave the Flag Recipient

Thank you Senior Research Scientist Joel Gaston, for your outstanding service and dedication to Geneva’s core values and mission! The photo above is Geneva Program Manager Linzie Wagner (L) with Q4 2018 Wave the Flag recipient Joel Gaston (R). An excerpt from his nomination states: “Joel Gaston was hired on to the 4D Bio3 team as

Read more
January 17, 2019

Geneva to Attend EWI 2019

President Elise Huszar, Program Manager Linzie Wagner, and Client Relationship Manager Kelli Blaize-Wise will be representing Geneva at the Extremity War Injuries (EWI) 14th Annual Meeting on 22-23 January in Washington, D.C. The symposium, titled “Evolving Combat Care and Readiness Research”, will identify the top orthopedic research priorities for the wounded warrior and tactical athlete. As

Read more
January 17, 2019

2019 Join the Conversation

The Geneva Foundation invites you to Join the Conversation on 5 February at 5:00 PM in Tacoma, WA with special guest speaker Dr. Brad Isaacson. Dr. Isaacson is a Principal Investigator, Geneva, a Director of Research & Operations, Collaboratory for Musculoskeletal Injury Rehabilitation Research (CMIRR), and a Scientific Director, The Center for Rehabilitation Sciences Research (CRSR).

Read more